Northern Trust’s Aprea Therapeutics APRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,436
Closed -$9.5K 4580
2022
Q4
$9.5K Hold
1,436
﹤0.01% 4580
2022
Q3
$19K Hold
1,436
﹤0.01% 4553
2022
Q2
$22K Sell
1,436
-24
-2% -$553 ﹤0.01% 4607
2022
Q1
$54K Sell
1,460
-288
-16% -$11.8K ﹤0.01% 4515
2021
Q4
$100K Sell
1,748
-22
-1% -$1.94K ﹤0.01% 4424
2021
Q3
$181K Buy
1,770
+143
+9% +$13K ﹤0.01% 4219
2021
Q2
$159K Sell
1,627
-3,659
-69% -$338K ﹤0.01% 4231
2021
Q1
$539K Sell
5,286
-385
-7% -$44.9K ﹤0.01% 3793
2020
Q4
$559K Sell
5,671
-230
-4% -$109K ﹤0.01% 3698
2020
Q3
$2.84M Buy
5,901
+358
+6% +$200K ﹤0.01% 2876
2020
Q2
$4.3M Buy
5,543
+1,484
+37% +$974K ﹤0.01% 2611
2020
Q1
$2.82M Buy
4,059
+89
+2% +$65.3K ﹤0.01% 2652
2019
Q4
$3.64M Buy
+3,970
New +$2.19M ﹤0.01% 2778

Other funds holding APRE